Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PURE BiosciencePURE +13.17% Gross Margin % is 53.16% as of Apr. 2026, which is 9% below its 10-year median of 58.31. The stock has 5 warning signs investors should review. Among 1,908 Consumer Packaged Goods companies, PURE Bioscience ranks better than 89.94% on this metric.
The historical rank and industry rank for PURE Bioscience's Gross Margin % or its related term are showing as below:
PURE'
s Gross Margin % Range Over the Past 10 Years
Min: 51.73 Med: 58.31 Max: 65.79
Current: 58.84
During the past 13 years, the highestGross Margin % of PURE Bioscience was 65.79%. The lowest was 51.73%. And the median was 58.31%.
PURE's Gross Margin % is ranked better than 89.94% of 1908
companies
in the Consumer Packaged Goods industry
Industry Median: 26.345
vs PURE: 58.84
PURE Bioscience had a gross margin of 53.16% for the quarter that ended in Apr. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for PURE Bioscience was 1.00% per year.
PURE Bioscience (OTCPK:PURE) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
PURE Bioscience had a gross margin of 53.16% for the quarter that ended in Apr. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
PURE Bioscience Gross Margin % Related Terms
PURE Bioscience Gross Margin % Historical Data
* Premium members only.
The historical data trend for PURE Bioscience's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PURE vs DQWS, RAY, TANH: Gross Margin % Comparison
For the Household & Personal Products subindustry, PURE Bioscience's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PURE Bioscience Gross Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, PURE Bioscience's Gross Margin % distribution charts can be found below:
* The bar in red indicates where PURE Bioscience's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
PURE Bioscience (PURE) has a Gross Margin % of 53.16% as of Apr. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on PURE Bioscience and its competitors. This is near median its historical median of 58.31. Over the past decade, PURE Bioscience's Gross Margin % has ranged from 51.73 to 65.79. According to the industry distribution chart, PURE Bioscience ranks #192 out of 1908 companies in the Consumer Packaged Goods industry, placing it in the top 10.1%.
Is PURE Bioscience's Gross Margin % too high?
PURE Bioscience's current Gross Margin % of 53.16% is near median its 10-year median of 58.31. Over the past 10 years, this metric has ranged from a low of 51.73 to a high of 65.79. The Consumer Packaged Goods industry median Gross Margin % is 26.35. PURE Bioscience's value of 53.16% is 101.8% above this industry median. Based on the distribution chart, PURE Bioscience ranks #192 out of 1908 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers.
How does PURE Bioscience's Gross Margin % compare to DQWS and RAY?
According to the Consumer Packaged Goods industry distribution chart, PURE Bioscience ranks #192 out of 1908 companies for Gross Margin %. This places PURE Bioscience in the top 10% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 26.35. PURE Bioscience's value of 53.16% is 101.8% above this benchmark. Historically, PURE Bioscience's own Gross Margin % has ranged from 51.73 to 65.79 over the past decade. While the company's 10-year median is 58.31 vs. the industry median of 26.35, PURE Bioscience has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Consumer Packaged Goods company?
The median Gross Margin % among Consumer Packaged Goods companies is 26.35, based on 1,908 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PURE Bioscience's current Gross Margin % of 53.16% is 101.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on PURE Bioscience and its competitors. For the Consumer Packaged Goods industry, the median Gross Margin % is 26.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PURE Bioscience's current Gross Margin % is 53.16%, which is near median its own 10-year median of 58.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PURE Bioscience stock overvalued right now?
Based on GuruFocus' analysis, PURE Bioscience (PURE) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.10, compared to a current price of $0.08 — trading 23.3% below its estimated fair value. The current Gross Margin % is 53.16%, which is near median its 10-year median of 58.31 and 101.8% above the Consumer Packaged Goods industry median of 26.35. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For PURE Bioscience (PURE), the current Gross Margin % is 53.16% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PURE Bioscience Inc is engaged in developing and commercializing proprietary antimicrobial products. The company's technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate, or SDC. It offers PURE Hard Surface as a food contact surface sanitizer and disinfectant to restaurant chains, food processors and food transportation companies and PURE Control as a direct food contact processing aid. It also manufactures and sells SDC-based products for end use, and products preserved with SDC and SDC as a raw material ingredient for manufacturing use. The company generates revenue from the sale of its antimicrobial products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PURE has been successfully added to your 
